Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000267102 is a pseudogene of the RAB32 gene and does not encode a functional protein. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they are generally considered remnants of genes that have lost their protein-coding ability. This pseudogene should not be confused with the protein-coding RAB32 gene, which participates in mitochondrial function, vesicle-mediated transport, and has disease associations including leprosy and Parkinson’s disease[2][1]. In summary, ENSG00000267102 is not a functional therapeutic target—it is a pseudogene related to the RAB32 family and should not be used for drug targeting, biomarker development, or functional studies[2]. For information regarding drug targets, use the protein-coding RAB32 gene (Ensembl: ENSG00000118508), not this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB32, member RAS oncogene family pseudogene.